Brinedew

Unpublished draft

Atavistic Theory of Cancer

The atavistic theory of cancer is an evolutionary framework proposing that cancer occurs when multicellular cells revert to ancient, unicellular survival and proliferation programs. Atavistic theory states that cancer is not a collection of random broken biological processes, but rather a coordinated ancestral mode of existence that cells enter under environmental stress. According to this view, oncogenic triggers disrupt the regulatory networks that normally suppress primitive traits, leading the cell to reactivate genetic machinery inherited from unicellular or early colonial ancestors. Consequently, cancer cells exhibit behaviors characteristic of single-celled organisms, including rapid division, motility, and a preference for anaerobic metabolism.

German biologist Theodor Boveri first introduced the premise of cancer as an evolutionary throwback in 1914. In 2011, physicists Paul Davies and Charles Lineweaver, along with oncologist Mark Vincent, formally expanded this concept into a quantitative model. Modern proponents support the theory using phylostratigraphy, a genomic mapping method that determines the evolutionary age of genes. Genomic research published in 2017 demonstrated that human tumors frequently overexpress genes originating from early unicellular organisms, while silencing genes that evolved later to support complex multicellular organs. This genetic profile helps explain why cancer exhibits highly predictable clinical progression across different tissue types despite the diverse and random mutations found within individual tumors.

By viewing cancer as an evolutionary reversion, the model suggests therapeutic strategies that target the weaknesses of ancient biological systems rather than trying to suppress their survival strengths. For example, treatments might exploit a tumor’s reliance on ancestral metabolic pathways, such as aerobic glycolysis, by introducing environmental stressors like hyperbaric oxygen that only recently evolved multicellular mechanisms can tolerate. However, the atavistic theory remains a minority view within oncology, where the somatic mutation theory remains the prevailing framework for cancer research. Critics argue that the model oversimplifies the complex, dynamic microenvironments of tumors and that random genetic instability, rather than a coordinated evolutionary program, explains the activation of ancient genes.

Core mechanism

Cancer happens when cells lose the regulatory controls that make multicellular life work, and fall back to ancestral single-cell behaviors:

  • Uncontrolled proliferation
  • Metabolic flexibility
  • Resistance to cell death signals
  • Ability to migrate and invade tissues
  • Independence from growth signals

These capabilities aren’t newly acquired through mutations - they’re ancient genetic programs that multicellular organisms normally keep turned off.

Serial atavism model

Davies and Lineweaver later refined this into the “serial atavism model.” Cancer progression follows a specific sequence that mirrors evolutionary history:

  1. Late multicellular reversion: Loss of growth control and apoptosis resistance
  2. Early multicellular reversion: Tissue invasion and metastatic capability
  3. Unicellular reversion: Metabolic reprogramming and immortalization

This sequence explains why cancer progression looks similar across different tissue types and species.

Evidence and predictions

This makes several testable predictions:

  • Cancer-associated genes should be phylogenetically ancient
  • Cancer progression should follow predictable patterns based on evolutionary timescales
  • Similar cancer behaviors should appear across distantly related species
  • Therapeutic interventions should target capabilities lost during cellular reversion

Phylostratigraphic analysis has shown that many cancer-associated genes are indeed ancient, though this evidence is also consistent with other theories.

Scientific reception

Cancer biologists haven’t bought into this theory. The main criticisms:

  • Lack of novelty: The concept of cancer as evolutionary reversion predates Davies and Lineweaver’s work by decades
  • Insufficient evidence: Phylogenetic conservation of cancer genes may reflect their essential cellular functions rather than atavistic activation
  • Mechanistic gaps: The theory doesn’t explain how specific mutations lead to selective reactivation of ancient pathways
  • Alternative explanations: Convergent evolution could account for similarities between cancer and single-cell behaviors

The theory has generated more interest in physics and astrobiology communities than in mainstream cancer research.

Therapeutic implications

If this theory is right, you’d want to target capabilities that cancer cells lose when they revert to ancestral states:

  • High-oxygen treatments to exploit reduced oxygen tolerance in ancient metabolic pathways
  • Metabolic interventions targeting glucose dependence
  • Therapies that challenge complex multicellular functions cancer cells have lost

These approaches remain largely experimental and theoretical.

Relationship to other theories

The atavistic theory overlaps with several established cancer concepts:

  • Oncogene activation: Many oncogenes regulate growth and survival pathways that would be beneficial in single-cell contexts
  • Tumor suppressor loss: Loss of tumor suppressors could represent removal of multicellular constraints
  • Metabolic reprogramming: The Warburg effect resembles ancient anaerobic metabolic strategies

However, these observations don’t necessarily support the specific atavistic mechanism over other explanations.

The atavistic theory remains controversial but continues to generate research and debate about the evolutionary roots of cancer.